期刊
MAYO CLINIC PROCEEDINGS
卷 91, 期 12, 页码 1778-1810出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.mayocp.2016.08.022
关键词
-
资金
- Boston Scientific
- Medtronic
As the most common sustained arrhythmia in adults, atrial fibrillation (AF) is an established and growing epidemic. To provide optimal patient care, it is important for clinicians to be aware of AF's epidemiological trends, methods of risk reduction, and the various available treatment modalities. Our understanding of AF's pathophysiology has advanced, and with this new understanding has come advancements in prevention strategies as well as pharmacological and nonpharmacological treatment options. Following PubMed and MEDLINE searches for AF risk factors, epidemiology, and therapies, we reviewed relevant articles (and bibliographies of those articles) published from 2000 to 2016. This state-of-the-art review provides a comprehensive update on the understanding of AF in the world today, contemporary therapeutic options, and directions of ongoing and future study. (C) 2016 Mayo Foundation for Medical Education and Research
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据